You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 8, August 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic

A Combination of Amoxicillin and Clavulanate Every 12 Hours vs Every 8 Hours for Treatment of Acute Bacterial Maxillary Sinusitis

Joram S. Seggev, MD; Ronel R. Enrique, MD; Milan L. Brandon, MD; L. Scott Larsen, MD; Ronald A. Van Tuyl, MD; Carolyn A. Rowinski, PharmD; and the Acute Bacterial Maxillary Sinusitis Collaborative Study Group

Arch Otolaryngol Head Neck Surg. 1998;124:921-925.

Objective  To compare the safety and efficacy of a combination of amoxicillin and clavulanate potassium given orally every 12 hours (amoxicillin, 875 mg; clavulanate, 125 mg) with that given every 8 hours (amoxicillin, 500 mg; clavulanate, 125 mg) for the treatment of patients with acute bacterial maxillary sinusitis.

Design  Multicenter double-blind randomized double-dummy controlled trial.

Setting  Physicians' offices and ambulatory care clinics.

Patients  One hundred seventy patients at least 18 years of age with acute bacterial maxillary sinusitis who could be treated with an oral antimicrobial agent were randomized, and data from 134 were suitable for evaluation. Four patients were withdrawn from this study because of adverse effects.

Interventions  Patients received a combination of amoxicillin and clavulanate orally every 12 hours (amoxicillin, 875 mg; clavulanate, 125 mg) or every 8 hours (amoxicillin, 500 mg; clavulanate, 125 mg) for 14 days.

Main Outcome Measure  Clinical success at the end of therapy.

Results  Clinical success at the end of therapy was similar for the 2 treatment groups, 93% and 88% of patients in the every 12-hour and every 8-hour groups, respectively (P=.76; 95% confidence interval,-4.0% to 15.6%). Clinical success rates at follow-up 2 to 4 weeks after the end of therapy were also similar in the 2 groups. Adverse events related to treatment were reported with similar frequency in the 2 groups.

Conclusion  Amoxicillin and clavulanate given every 12 hours is as effective and as safe as administration every 8 hours for the treatment of acute bacterial maxillary sinusitis.


From the Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas (Dr Seggev); Piedmont Health Care, Statesville, NC (Dr Enrique); California Research Foundation, San Diego (Dr Brandon); Emergency Medical Offices, Clinical Research Division, Middletown, NJ (Dr Larsen); Insite Clinical Trials, Atlanta, Ga (Dr Van Tuyl); and SmithKline Beecham Pharmaceuticals, Collegeville, Pa (Dr Rowinski).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.